Lyme Disease Mandated Benefit I
SECTION 108.
Chapter 175 of the General Laws is hereby amended by inserting after section 47GG the following section:-
Section 47HH. (a) For the purposes of this section, "Lyme disease" and "Long-term antibiotic therapy" and "Lyme disease" shall have the same meaning as ascribed to them in section 12DD of chapter 112.
(b) A policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth that provides medical expense coverage shall provide coverage for long-term antibiotic therapy for a patient with Lyme disease when determined to be medically necessary and ordered by a licensed physician after making a thorough evaluation of the patient's symptoms, diagnostic test results, or response to treatment. An experimental drug shall be covered as a long-term antibiotic therapy if it is approved for any indication by the United States Food and Drug Administration; provided, however, that a drug, including an experimental drug, shall be covered for an off-label use in the treatment of Lyme disease if the drug has been approved by the United States Food and Drug Administration.